rBMA:一个强大的贝叶斯模型平均方法,用于II阶段的篮子试验,基于信息化的混合先验
1Department of Biostatistics, Yale School of Public Health, New Haven, CT 06520, United States of America.
这项研究引入了强大的贝叶斯模型平均 (rBMA) 方法用于瘤篮试验. rBMA技术通过实现跨指标学习来增强统计能力,即使具有混合的终点.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 向疗法已经推进了瘤学药物研究.
- 篮子试验测试了具有共享基因组改变的各种指示的抗瘤活性.
- 碎片化的患者群体需要改善篮子试验的统计方法.
研究的目的:
- 提出一个强大的贝叶斯模型平均化 (rBMA) 技术,用于II期瘤篮试验.
- 促进跨指标学习,提高篮子试验设计中的统计能力.
- 开发一种灵活的方法,可以适应各种指示的混合二进制终点.
主要方法:
- 提出了一个强大的贝叶斯模型平均 (rBMA) 技术.
- 使用三个具有不同先验的模型 (热情,悲观,非信息) 的加权后部分布.
- 根据所有适应症的治疗效果确定后部体重.
主要成果:
- rBMA方法在支持混合终点的跨指示学习方面表现出灵活性.
- 模拟研究评估和比较rBMA与竞争方法的性能.
- 拟议的方法提高了第二阶段篮子试验中的统计能力.
结论:
- rBMA技术为设计和分析II期瘤篮试验提供了一个强大的统计框架.
- 这种方法有效地实现了跨指标学习,在生物标志物定义的子组中尤其有价值.
- 对于具有异质终点的试验,rBMA方法提供了灵活的解决方案,推进了瘤学试验方法.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
